Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-20-008166

EVP, North America Commercial sold 4,799 shares at $12.27 ($58,884)

  • EVP, North America Commercial acquired 16,120 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

O'Grady Brendan P. · EVP, North America Commercial

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-02-09 Exercise or conversion : show line 1 in the form +16,120 18,255.49 D
2020-02-10 Sale : show line 2 in the form −4,799 $12.27 $58,884 13,456.49 D
Open-market sales · 4,799 sh · avg $12.27 · $58,884

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-02-09 Exercise or conversion : show line 3 in the form Restricted Share Units −16,120 32,241 D
Loading xslF345X03/doc4.xml…